Adverse Pregnancy Outcomes After Abnormal First-Trimester Screening for Aneuploidy
Author:
- 1 September 2010
- journal article
- review article
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 30 (3) , 613-628
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Pregnancy outcome in the setting of extremely low first trimester PAPP‐A levelsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2009
- First trimester predictors of adverse pregnancy outcomesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2008
- Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two‐vessel cord, and hydrocelePrenatal Diagnosis, 2008
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm deliveryUltrasound in Obstetrics & Gynecology, 2008
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Omphalocele‐exstrophy‐imperforate anus‐spinal defects (OEIS) complex associated with increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 2003
- Detection of fetal structural abnormalities at the 11–14 week ultrasound scanPrenatal Diagnosis, 2002
- FETAL OUTCOME IN NUCHAL TRANSLUCENCY WITH EMPHASIS ON NORMAL FETAL KARYOTYPEPrenatal Diagnosis, 1996
- Achondrogenesis type I diagnosed by transvaginal ultrasonography at 13 weeks' gestationAmerican Journal of Obstetrics and Gynecology, 1995
- Increased first trimester nuchal translucency as a prenatal manifestation of Smith‐Lemli‐Opitz syndromeAmerican Journal of Medical Genetics, 1995